Stop Dreaming: Mavacamten REMS Data Are Here
- PMID: 39523953
- DOI: 10.1161/CIRCHEARTFAILURE.124.012545
Stop Dreaming: Mavacamten REMS Data Are Here
Keywords: Editorials; cardiac myosins; cardiology; myosins; oxygen consumption.
Conflict of interest statement
Dr Masri reports research grants from Pfizer, Ionis, Attralus, and Cytokinetics and consulting fees from Cytokinetics, Bristol Myers Squibb (BMS), BridgeBio, Pfizer, Ionis, Lexicon, Attralus, Alnylam, Haya, Alexion, Akros, Lexeo, Prothena, BioMarin, AstraZeneca, and Tenaya. Dr Lakdawala reports research grants from Pfizer and BMS and consulting fees from Pfizer, BMS, Cytokinetics, Alexion, Neuvocor, Solid Biosciences, and Akros.
Comment on
-
Mavacamten: Real-World Experience From 22 Months of the Risk Evaluation and Mitigation Strategy (REMS) Program.Circ Heart Fail. 2025 Jan;18(1):e012441. doi: 10.1161/CIRCHEARTFAILURE.124.012441. Epub 2024 Nov 11. Circ Heart Fail. 2025. PMID: 39523955 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
